Bernice Ellis

539 total citations
10 papers, 434 citations indexed

About

Bernice Ellis is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Bernice Ellis has authored 10 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Bernice Ellis's work include Diabetes Treatment and Management (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Pancreatic function and diabetes (3 papers). Bernice Ellis is often cited by papers focused on Diabetes Treatment and Management (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Pancreatic function and diabetes (3 papers). Bernice Ellis collaborates with scholars based in United States and United Kingdom. Bernice Ellis's co-authors include Fabián Tibaldi, Karen Schneck, H. D. Hollis Showalter, Peggy L. Barrington, Jenny Y. Chien, Wolfgang Glaesner, Yu Tian, Anja Köester, Andrew Vick and Niels Pörksen and has published in prestigious journals such as Neurology, Journal of Pharmacology and Experimental Therapeutics and Bioorganic & Medicinal Chemistry.

In The Last Decade

Bernice Ellis

10 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernice Ellis United States	7	313	233	158	82	60	10	434
Rhonda Huerbin United States	5	319 1.0×	156 0.7×	154 1.0×	49 0.6×	34 0.6×	6	518
Holly J. Clarke United States	7	165 0.5×	266 1.1×	141 0.9×	21 0.3×	36 0.6×	8	393
Takahiro Kawai Japan	9	211 0.7×	164 0.7×	153 1.0×	45 0.5×	13 0.2×	35	409
Lene Jensen Denmark	9	722 2.3×	459 2.0×	330 2.1×	156 1.9×	27 0.5×	11	846
Agnès Portron Switzerland	10	147 0.5×	107 0.5×	63 0.4×	81 1.0×	13 0.2×	13	529
Deborah T. Cirkel United Kingdom	8	463 1.5×	221 0.9×	157 1.0×	110 1.3×	9 0.1×	8	529
Aditya Goud United States	9	169 0.5×	110 0.5×	109 0.7×	42 0.5×	10 0.2×	24	332
Yang Wei China	6	285 0.9×	142 0.6×	173 1.1×	36 0.4×	8 0.1×	10	447
Iresha Welungoda Australia	6	339 1.1×	206 0.9×	99 0.6×	89 1.1×	4 0.1×	7	475
Naomitsu Kuwamura Japan	7	248 0.8×	282 1.2×	114 0.7×	37 0.5×	11 0.2×	7	490

Countries citing papers authored by Bernice Ellis

Since Specialization

Citations

This map shows the geographic impact of Bernice Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernice Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernice Ellis more than expected).

Fields of papers citing papers by Bernice Ellis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernice Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernice Ellis. The network helps show where Bernice Ellis may publish in the future.

Co-authorship network of co-authors of Bernice Ellis

This figure shows the co-authorship network connecting the top 25 collaborators of Bernice Ellis. A scholar is included among the top collaborators of Bernice Ellis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernice Ellis. Bernice Ellis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Blankenship, Ross L., et al.. (2020). Influence of FcRn binding properties on the gastrointestinal absorption and exposure profile of Fc molecules. Bioorganic & Medicinal Chemistry. 32. 115942–115942. 8 indexed citations

Datta‐Mannan, Amita, Lihua Huang, Zhiying Jin, et al.. (2018). Engineered FcRn Binding Fusion Peptides Significantly Enhance the Half-Life of a Fab Domain in Cynomolgus Monkeys. Biotechnology Journal. 14(3). 1800007–1800007. 8 indexed citations

Ellis, Bernice, et al.. (2016). Peripheral and Central Nervous System Distribution of a CGRP Neutralizing Antibody [ ¹²⁵ I]-LY2951742 in Male Rats (I3.002). Neurology. 86(16_supplement). 2 indexed citations

Ellis, Bernice, et al.. (2016). Peripheral and Central Nervous System Distribution of a CGRP Neutralizing Antibody [ ¹²⁵ I]-LY2951742 in Male Rats (S26.007). Neurology. 86(16_supplement). 2 indexed citations

Ellis, Bernice, et al.. (2016). Peripheral and Central Nervous System Distribution of a CGRP Neutralizing Antibody [125I]-LY2951742 in Male Rats (S26.007). 86. 2 indexed citations

Knadler, Mary Pat, Bernice Ellis, Patricia Brown‐Augsburger, et al.. (2015). Disposition of Basal Insulin Peglispro Compared with 20-kDa Polyethylene Glycol in Rats Following a Single Intravenous or Subcutaneous Dose. Drug Metabolism and Disposition. 43(10). 1477–1483. 11 indexed citations

Petrovan, Ramona J., Elaine M. Conner, Derek Yang, et al.. (2014). Generation and Activity of a Humanized Monoclonal Antibody That Selectively Neutralizes the Epidermal Growth Factor Receptor Ligands Transforming Growth Factor-α and Epiregulin. Journal of Pharmacology and Experimental Therapeutics. 349(2). 330–343. 13 indexed citations

Barrington, Peggy L., Jenny Y. Chien, Fabián Tibaldi, et al.. (2011). LY2189265, a long‐acting glucagon‐like peptide‐1 analogue, showed a dose‐dependent effect on insulin secretion in healthy subjects. Diabetes Obesity and Metabolism. 13(5). 434–438. 62 indexed citations

Barrington, Peggy L., Jenny Y. Chien, H. D. Hollis Showalter, et al.. (2011). A 5‐week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long‐acting glucagon‐like peptide‐1 analogue, in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 13(5). 426–433. 95 indexed citations

10.

Glaesner, Wolfgang, Andrew Vick, Rohn Millican, et al.. (2010). Engineering and characterization of the long‐acting glucagon‐like peptide‐1 analogue LY2189265, an Fc fusion protein. Diabetes/Metabolism Research and Reviews. 26(4). 287–296. 231 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact